Dan Boehnen is a patent attorney and founding partner of the Chicago-based law firm of McDonnell, Boehnen. His legal efforts reach into a number of fields, including biotechnology, pharmaceuticals, computing, and chemicals. Among his current clients is RNAi drug development firm Sirna Therapeutics. RNAi News recently spoke to Boehnen on his views about the rapidly changing sector.
How did you first get interested in RNAi?